Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Immunaeon logo — Connecting Today's Science to Tomorrow's Cures

Immunaeon

Connecting Today's Science to Tomorrow's Cures

Founded 2019 United States Buffalo, United States 5 employees Total: $480.00K Biopharma, Biotechnology +2

General Information

Company Name Immunaeon
Founded Year 2019
Location United States Buffalo, United States
Employees 5
Industries Biopharma, Biotechnology, Health Care +1
Business Model B2C, D2C, B2B
Revenue Model Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Immunaeon. To contact Immunaeon, visit immunaeon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Immunaeon compare?

A PDF of Immunaeon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Immunaeon soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Immunaeon

Immunaeon, known for its slogan "Connecting Today's Science to Tomorrow's Cures", is a biotech pioneer established in 2019 in the United States. The company positions itself at the forefront of immunotherapy and biotechnology innovation, aiming to transform healthcare by leveraging advanced genetics and computational sciences.

Focusing on serious diseases like cancer, autoimmune, and infectious diseases, Immunaeon is dedicated to discovering precision-targeted therapeutics that enhance the body's immune response. The organization combines the talents of scientists, clinicians, and bioengineers to foster breakthroughs in medical science.

The latest investment totaling $250.00K was received as an angel investment from University Ventures on 01 March 2023, indicating strategic interest and financial backing. As part of the Biopharma and Health Care industries, Immunaeon continually seeks to push the boundaries of medical research, promising bright prospects for investors focused on transformative healthcare solutions.

Business keywords: immunotherapy, genetic sciences, computational sciences, precision-targeted therapeutics, cellular biology, cancer treatment, autoimmune disorders, infectious diseases, immune cell storage, breakthrough treatments, immunology research, therapeutic innovation, immune system analysis, healthcare transformation

Services & Products

immune cell isolation
cell analysis and preservation
immunotherapy preparation
health resilience planning

Target Customers

individuals with a family history of cancer individuals with autoimmune disorders health-conscious individuals patients seeking proactive healthcare

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Angel $250.00K 1
University Ventures
University Ventures
01 Mar 2023
Seed $100.00K 1
University Ventures
University Ventures
01 Jun 2022
Seed $100.00K 1
University Ventures
University Ventures
01 Oct 2021
Grant $30.00K 1
UB Incubators
01 Sep 2020

Immunaeon Alternatives & Competitors

View All Alternatives
Immunaeon vs
Greywolf Therapeutics
Greywolf Therapeutics United Kingdom

We are advancing novel antigen modulation technology that controls T cells to guide the immune syste...

Series B
49 employees
Biotechnology, Health Care
Compare Immunaeon vs Greywolf Therapeutics
Immunaeon vs
RemedyBio
RemedyBio Ireland

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...

Venture round
7 employees
Biotechnology, Health and Wellness
Immunaeon vs
Iyuda Therapeutics
Iyuda Therapeutics

Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments

Venture round
Biopharma, Biotechnology
View all alternatives

FAQ About Immunaeon

Connecting Today's Science to Tomorrow's Cures
Immunaeon was founded in 2019.
Immunaeon is headquartered in Buffalo, United States.
Immunaeon operates in Biopharma, Biotechnology, Health Care and Health and Wellness. Its work centres on immunotherapy, genetic sciences, computational sciences and precision-targeted therapeutics. Its customers include individuals with a family history of cancer, individuals with autoimmune disorders and health-conscious individuals.
Immunaeon has a B2C, D2C and B2B business model. Its revenue comes from Service Fee and Subscription.
Immunaeon has approximately 5 employees.
Immunaeon has completed 4 funding rounds, raising a total of $480.00K.
Immunaeon offers: immune cell isolation, cell analysis and preservation, immunotherapy preparation, health resilience planning.
Top alternatives and competitors to Immunaeon include Greywolf Therapeutics, RemedyBio, Iyuda Therapeutics, Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC., Rubik Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunaeon and Greywolf Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Immunaeon, https://bouncewatch.com/company/immunaeon, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes